Reviewers say Moderna's and Pfizer's shots appear safe and effective for children as young as 6 months old, with side effects minor and less common than in adults

FDA says children who received the kid-sized shots developed strong immune response to fight off coronavirus; decision on approval likely soon

US-based company will charge only manufacturing costs and 'minimal' distribution fees; most target countries are in Africa, along with Haiti, Syria, Cambodia, North Korea

Peer-reviewed Israeli research likely to be widely noted worldwide as health authorities debate whether to administer 4th doses to the general population

Rejecting ‘unfounded claims in popular media,’ peer-reviewed 428-woman research shows 25% of IVF transfers result in pregnancy, regardless of vaccination status, COVID infection

Natural immunity alone much weaker than recovery-plus-shot, mass peer-reviewed research finds; before Omicron, those with ‘hybrid’ protection were 82% less likely to be reinfected

Health reporter Nathan Jeffay offers some rays of light from a waning Omicron wave; news editor Luke Tress dives into messianic Jewish missionaries and a virtual Chabad house

Sheba Medical Center will administer 200 doses of a new shot designed to have increased effectiveness against the variant as part of new research

Top US health group finds Pfizer and Moderna shots given to expecting mothers cut the rate of later coronavirus infection among their babies in half

Sheba Medical Center said to be readying to participate in study; trial to consist of those over 60 who haven't yet had 2nd booster shot, mainly staff members and their families